Results 211 to 220 of about 279,139 (356)
Considerations for drug trials in hypertrophic cardiomyopathy
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant +17 more
wiley +1 more source
Memantine use and risk of cardiac arrhythmias in Alzheimer dementia: a report from a global federated research network. [PDF]
Fauchier L +5 more
europepmc +1 more source
2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias [PDF]
Cuculich, Phillip, et al,
core +1 more source
Abstract Background Obesity is a known risk factor for cardiovascular disease (CVD), yet an ‘obesity paradox’ has been observed in various CVD contexts. The impact of obesity on heart failure (HF) patients treated with a wearable cardioverter‐defibrillator (WCD) remains underexplored.
Mohammad Abumayyaleh +18 more
wiley +1 more source
Transformer-based ECG classification for early detection of cardiac arrhythmias. [PDF]
Ikram S +7 more
europepmc +1 more source
Abstract Objective This study aimed to evaluate the utility of left atrial volume and function in uraemic patients using four‐dimensional automatic left atrial quantification (4D auto LAQ) technology. Methods Thirty‐four undialysed uraemic patients (U‐ND group), 60 dialysed uraemic patients (U‐D group), and 32 healthy volunteers (N group) were enrolled
Bing Li, Meihua Chen, Xuning Huang
wiley +1 more source
The alarmin tandem: unraveling the complex effect of S100A8/A9 - from atherosclerosis to cardiac arrhythmias. [PDF]
Cozac DA, Halațiu VB, Scridon A.
europepmc +1 more source
Natural Protection Against Cardiac Arrhythmias During Hibernation: Significance of Adenosine
T. Kalyan Ram
openalex +2 more sources
Abstract Aims Amyloid cardiomyopathy is caused by the deposition of light chain (AL) or transthyretin amyloid (ATTR) fibrils, that leads to a restrictive cardiomyopathy, often resulting in heart failure (HF) with preserved or reduced ejection fraction.
Robin Willixhofer +25 more
wiley +1 more source
The Rhythms of the Moon: Can the Moon Affect Cardiac Arrhythmias? [PDF]
Ziakos A, Sause A, Seyfarth M.
europepmc +1 more source

